Zhitong Financial App News, and Platinum Pharmaceutical-B (02142.HK) announced that Nona Biotech (Nona), a wholly-owned subsidiary of the company, has successfully developed hCABlm — the world's first language model based on wholly human-derived heavy chain antibodies (HCABs) training. The related research paper “A Foundation Model Approaches the Sequence and Functional Grammar of Fully Human Heavy-Chain-Only Combinations” has been published on bioRXiv.

Zhitongcaijing · 2d ago
Zhitong Financial App News, and Platinum Pharmaceutical-B (02142.HK) announced that Nona Biotech (Nona), a wholly-owned subsidiary of the company, has successfully developed hCABlm — the world's first language model based on wholly human-derived heavy chain antibodies (HCABs) training. The related research paper “A Foundation Model Approaches the Sequence and Functional Grammar of Fully Human Heavy-Chain-Only Combinations” has been published on bioRXiv.